The use of herbomineral formulations for different chronic diseases is gaining popularity because these natural formulations have fewer side effects, a higher safety profile, and more cost effectiveness. A new proprietary herbomineral formulation composed of herbs and certain minerals was formulated, consisting of the herbal root extract ashwagandha and the minerals (zinc, magnesium, and selenium). The aim of the study was to evaluate the immunomodulatory potential of a Biofield Energy Healing (The Trivedi Effect®) Treatment on the herbomineral formulation in female Sprague Dawley rats. The test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely from eighteen renowned Biofield Energy Healers. Immunomodulatory potential, humoral immune response, paw volume, hematological study, biochemistry, body weight, feed intake and histopathology analysis were performed. Humoral immune response data showed increased (p≤0.01) primary antibody titre by 124.7% in the Biofield Treatment test formulation (G3), while the untreated test formulation group (G4) showed decreased antibody titre compared with the disease control group (G2). The secondary antibody titre value in the G3 group was also altered compared with the G2 group. Delayed type hypersensitivity (DTH) data suggest that the Biofield Energy Treated test formulation group (G3) showed a significant decrease in paw volume by 128.57% with respect to the G2 group. Hematology and biochemistry analysis showed altered values, as increased MCHC and RBC count by 138.09% and 7.24%, respectively in the G3 group compared with the G2 and G4 group. However, the platelet count was increased by 17.70% in the G3 group compared with the G2 group. The level of blood urea nitrogen was decreased by 10.90% in the G3 level compared with the G2 group. However, the levels of magnesium and phosphorus were increased by 13.29% and 6.28%, respectively in the G3 compared with the G2 group. Further, the change in body weight, feed consumption, organ to body weight ratio data, and histopathology examination did not suggest any statistical difference, which depicts that the Biofield Energy Treated test formulations was found to be safe. These data suggest that the Biofield Treated test formulation can be used for autoimmune and inflammatory diseases such as Rheumatoid arthritis, Alzheimer’s disease, Atherosclerosis, Dermatitis, Diverticulitis, Diabetes, etc. along with enhancing stress management and anti-aging by improving overall health.
A new proprietary herbomineral formulation was formulated, consisting of essential ingredients viz. herbal root extract ashwagandha and minerals (zinc, magnesium, and selenium). The aim of the study was to evaluate the immunomodulatory potential of Consciousness Energy Healing Treatment on the herbomineral formulation in male Sprague Dawley rats. The test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely from seven renowned Biofield Energy Healers. Additionally, one group of animals also received Biofield Energy Treatment per se (day -15) by Biofield Energy Healers under similar conditions. The test formulation was evaluated for immunological parameters viz. humoral immune analysis, paw volume, hematological study, biochemistry, body weight, feed and water intake, and histopathology analysis were performed. The humoral immune response showed a significant increased primary and secondary antibody titre values by 26% and 150.4%, respectively in Biofield Energy Treatment per se group (G6, day -15), while primary and secondary antibody titre values were increased by 100.0% and 110.4%, respectively in the Biofield Energy Treated test formulation (G7, day -15) group compared with the disease control group (G2). The results of delayed type hypersensitivity showed a significant increase in the paw volume by 94.44% in the Biofield Energy Treated test formulation (G4) group with respect to the G2 group. However, a significant increase in paw volume by 61.11% and 44.44% was found in G6 and G7 group, respectively with respect to the G2 group. Hematological parameters showed a significant (p<0.001) increased platelet count by 85.6% in the G4 group, while 39.15% and 35.22% increase in the G6 and G7 groups, respectively compared with the G2 group. In biochemical analysis, a significant increase in calcium and phosphorus level were found in the G4 group compared with the G2 group. Animal weight parameters suggests that there were no treatment-related changes in any group, organ to body weight ratio, feed and water intake. The data described that the Biofield Energy Treated test formulation was found to be safe without any side effect during the course of the experiment. These data suggests that the Biofield Energy Treated test formulation and Biofield Energy Treatment per se can be used for autoimmune and inflammatory diseases, enhancing stress management and prevention, and anti-aging by improving overall health.
The present study aimed to evaluate the impact of The Trivedi Effect®- Energy of Consciousness Healing Treatment based new proprietary herbomineral formulation and Energy Healing Treatment per se in male Sprague Dawley rats for immune biomarkers modulation. The test formulation was divided into two parts, one as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely from seven renowned Biofield Energy Healers. Additionally, one group of animals also received Biofield Energy Treatment per se (day -15) by under similar conditions. Humoral immune response data showed an increased level of IgG by 2.89%, 6.20%, and 6.20% in the Biofield Energy Treated test formulation group (G4), Biofield Energy Treatment group per se (G6), and Biofield Energy Treated test formulation at day -15 (G7), respectively as compared with the disease control group (G2). The ratio of CD4+/CD8+ was increased by 3.80%, 12.38%, and 16.19% in the G4, G6, and G7, respectively compared with the G2. Hematology analysis suggested an increased level of TLC and neutrophil by 9.64% and 1.48%, respectively in the G4 group, while G6 group showed an increase count of TLC, lymphocytes, and monocytes by 19.79%, 2.87%, and 15.54%, respectively compared with the G2. Biochemical study showed an increased concentration of glucose by 11.78%, 18.60%, and 56.84% in the G4, G6, and G7, respectively compared with G2. Total cholesterol was significantly decreased by 10.54% and 4.20% in the G4 and G7, respectively compared with G2. In contrast, the HDL level was increased by 11.69% and 1.06% in G6 and G7, respectively while LDL was decreased by 10.52% in G4 compared with the G2. SGOT, CK-MB, total protein, albumin, and globulin levels were decreased by 4.04%, 23.54%, 1.68%, 1.54%, and 1.80%, respectively in G4, while G6 group showed decreased level of SGOT, CK-MB, and A/G ratio by 2.08%, 16.23%, and 3.40%, respectively compared with G2. However, SGOT was significantly decreased (p≤0.01) by 18.88% in G7 compared with G2. The testosterone level was decreased by 76.67%, 18.43%, and 44.06% in G4, G6, and G7, respectively compared with G2. Antioxidant profile showed a decreased level of LPO by 59.63% in G7, while SOD and CAT levels were significantly altered in tested groups compared with G2. Biofield Energy may also be used for autoimmune and inflammatory diseases, stress management and prevention, and anti-aging by improving overall health.